Poland· PL-100455127

Argosulfan

A sulfathiazole product containing sulfathiazolum argentum, registered in Poland by InPharm Sp. z o.o..

ATC D06BA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedArgosulfanATCD06BA02REGISTER NO.PL-100455127PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Sulfathiazolum argentum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
D06BA02
ATC class
Sulfathiazole
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991459253

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/65350d46-97a8-4734-8747-46bc35c8dd1e
GET /v1/drugs/65350d46-97a8-4734-8747-46bc35c8dd1e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "urpl",
  "strength": "20 mg/g",
  "packaging": "05909991459253 ¦ Rp ¦ 141035\n1 tuba 40 g",
  "substance": "Sulfathiazolum argentum 20 mg/g",
  "common_name": "Sulfathiazolum argentum",
  "pl_product_id": "100455127",
  "pozwolenie_nr": "250/21",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-07-19"
}

See everything about sulfathiazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.